D

Druggpt

Developed by liyuesen
DrugGPT is a generative drug design model based on the GPT2 architecture, bringing innovation to drug design through natural language processing technology.
Downloads 495
Release Time : 4/16/2023

Model Overview

DrugGPT applies the GPT model to chemical space exploration to discover new molecules with potential binding capabilities for specific proteins. Trained on 1.8 million protein-ligand binding data points, it provides a fast and efficient method for generating candidate drug molecules.

Model Features

Large-Scale Data Training
Trained on 1.8 million protein-ligand binding data points to ensure the reliability of generated molecules.
Efficient Molecule Generation
Capable of rapidly generating candidate drug molecules for specific proteins.
Ligand Prompt Support
Users can guide the molecule generation process by inputting ligand prompts.

Model Capabilities

Generate candidate drug molecules
Explore chemical space
Protein-ligand binding prediction

Use Cases

Drug Discovery
Targeted Drug Design
Generate potential small molecule ligands for specific proteins.
Generate 50 candidate molecules
Featured Recommended AI Models
AIbase
Empowering the Future, Your AI Solution Knowledge Base
Š 2025AIbase